For the first time in Europe, McPhy will be presenting

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
57
For the first time in Europe, McPhy will be presenting SimpleFuelTM, the all-in-one hydrogen station, at the Hannover Messe trade fair

 Press release

For the first time in Europe, McPhy will be presenting SimpleFuel TM , the all-in-one hydrogen station , at the Hannover Messe trade fair

Join us in Hall 27, Stand D70 from 24 to 28 April

 
   

For the first time ever in Europe, McPhy will be presenting an exclusive preview of the SimpleFuelTM hydrogen refueling station at the 2017 Hannover Messe trade fair, the world's leading industrial technology event. McPhy is the exclusive distributor in Europe for this solution, which it has jointly developed in the US to facilitate the widespread adoption of zero emission mobility. With its compact, all-in-one design, SimpleFuelTM is a fully integrated hydrogen generation, compression, storage and dispensing system, serving commercial fleets, car dealerships, service stations, logistics platforms.

La Motte-Fanjas, 24 April 2017 - McPhy, the designer, manufacturer and integrator of hydrogen equipment for the energy, transport and industrial sectors, will be presenting the SimpleFuel TM hydrogen refueling station at the 2017 Hannover Messe trade fair from 24 to 28 April. The Group, which has jointly developed SimpleFuel TM with its US partners Ivys Energy Solutions and PDC Machines, manages its production at its San Miniato plant (Italy) and has exclusive distribution rights for Europe. Preorders are being taken, with the first deliveries scheduled for the end of 2017.

SimpleFuel TM is a turnkey, compact and affordable refueling station. A genuine "energy hub" , it is a fully integrated hydrogen generation, compression, storage and dispensing system capable of delivering 5-10 kg/day at pressures up to 700 bar. In January this year, the US Department of Energy (DOE) awarded the $1 million first prize from its H2 Refuel H-Prize competition to SimpleFuel TM . This competition, organized by the Hydrogen Education Foundation (HEF), aimed to promote the development of on-site affordable small-scale hydrogen refueling systems with a view to accelerating the deployment of hydrogen infrastructure across the US to contribute to the widespread adoption of zero emission mobility .

The compact physical footprint of SimpleFuel(TM) offers extensive opportunities for installation at all types of locations, even space-constrained, both indoors and outdoors: commercial fleets, car dealerships, service stations, logistics platforms.

"We have worked closely with our US partners over the last two years on the technological and industrial development of this revolutionary hydrogen refueling station combining performance, affordability and accessibility. With SimpleFuel (TM) , hydrogen is simpler than ever. Easy to install, all-in-one and user-friendly, SimpleFuel (TM) will accelerate the deployment of hydrogen infrastructures. In this way, it will facilitate the widespread adoption of zero emission mobility, while making it possible to monetize renewable energy surplus" , concluded McPhy's Chairman and CEO, Pascal Mauberger.

On 26 April, from 2:40 pm, Bertrand Amelot, McPhy's Executive Vice President Sales & Marketing, will be speaking about "SimpleFuel(TM): game-changing H2 refueling station - an all-in-one production, storage and dispensing solution" during the "Hydrogen + fuel cells + batteries" public forum in Hall 27, Stand C66.

About McPhy

As a specialised supplier of hydrogen production, storage and distribution equipment, McPhy contributes to the deployment of clean hydrogen as a solution for achieving energy transition.

Through its wide range of products and services dedicated to the hydrogen energy, zero emission mobility and industrial hydrogen markets, McPhy provides turnkey solutions tailored to client applications: renewable energy surplus storage and monetization, fuel cell car refuelling, raw material for industrial sites

As a designer, manufacturer and integrator of hydrogen equipment since 2008, McPhy has three development, engineering and production units based in Europe (France, Italy, Germany). The company's international subsidiaries ensure a global sales coverage of McPhy's innovative hydrogen solutions.

McPhy is listed on NYSE Euronext Paris (Segment C, ISIN code: FR0011742329; ticker: MCPHY).

Media relations Calyptus Marie-Anne Garigue T. +33 (0)1 53 65 68 63 marie-anne.garigue@calyptus.net   Follow us at    @McPhyEnergy   

 

Attachments:

http://www.globenewswire.com/NewsRoom/Attachm...d44bee5adc

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 78

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 236

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 273

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 337

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 501

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
LG's ASIL D Certification: A Game Changer in Autos

Updated Category News Views 15

Why LG's ASIL D Certification Matters There ain't much in the tangled mess of automotive innovations these days that'll make a seasoned investor raise an eyebrow, but here comes LG Electronics grabbing the ASIL D certification like it's a badge of market honor. The ISO 26262 ASIL D is no walk in the park, folks—it's the top rung on the safety ladder, something that's...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 45

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading
Antengene’s AnTenGager-D2 Advances in Cancer Treatment

Updated Category News Views 31

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

Continue Reading
FFR's OmniMind Takes Top Spot In RoboColiseum Rankings

Updated Category News Views 55

The AI Race Heats Up with FFR's Big Win Stop the presses—FFR's OmniMind AI just snagged the top spot on RoboColiseum's global rankings. Yeah, you heard right, this ain't just some run-of-the-mill news. As of November 6, they've parked themselves in pole position, beating out heavyweights like NVIDIA's GR00T N1.7 and GPT-6 Astra. That's like hitting a grand slam right...

Continue Reading
CureGene's Evategrel Aims for Breakthrough in Stroke Care

Updated Category News Views 69

Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...

Continue Reading

Top 5 Most Recently Viewed Articles

Eco Wave Power Expands Wave Energy Project in Europe

Updated Category News Views 229

Eco Wave Power Initiates Key Infrastructure Enhancements Eco Wave Power Global AB (publ) (NASDAQ: WAVE) is excited to unveil plans for crucial upgrades at its groundbreaking wave energy project. This groundbreaking initiative is set to harness ocean wave energy to produce clean electricity efficiently. Eco Wave Power, recognized as a leading company in onshore wave energy...

Continue Reading
Key Managerial Transactions Reported by Danske Bank A/S

Updated Category News Views 162

Recent Mandatory Transaction Notifications by Danske Bank A/S Danske Bank A/S is committed to transparency in financial transactions involving its managerial personnel. This communication signifies the bank's adherence to the EU Market Abuse Regulation and the requirements set by the Danish Financial Supervisory Authority (FSA) and Nasdaq Copenhagen. Understanding...

Continue Reading
Strategic Insights into Symbotic's Options Market Activity

Updated Category News Views 187

Overview of Options Activity for Symbotic Recently, significant investors have demonstrated a notably bearish outlook on Symbotic. This trend has been evidenced by the options activity surrounding the company's stock, symbolized by SYM. The strong presence of whales entering the market indicates a shift in investor sentiment, with nuances that are crucial for...

Continue Reading
South Coast AQMD Takes Action on Oil Facilities During Violations

Updated Category News Views 267

South Coast AQMD Addresses Oil Site Violations In a determined effort to safeguard public health and air quality, the South Coast Air Quality Management District (South Coast AQMD) has recently taken enforcement action against three oil and gas facilities in Los Angeles. These actions were prompted by public complaints and confirmed violations of air quality regulations,...

Continue Reading
BAM UK & Ireland and LoadSpring Solutions Innovate Project Management

Updated Category News Views 199

BAM UK & Ireland and LoadSpring Solutions Innovate Project Management BAM UK & Ireland, a prominent name in the construction and engineering sector, has taken a bold step forward by partnering with LoadSpring Solutions. This collaboration aims to revolutionize project management through an innovative solution known as LoadSpring INSIGHTS™. This groundbreaking platform...

Continue Reading